CHICAGO, SEPTEMBER 24, 2021 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named EVERSANA a Trailblazer 2021 winner in two categories. ACTICS by EVERSANA™ earned GOLD in the Data/Analytics Category, and EVERSANA ENGAGE was recognized with SILVER in the Sales Aid Category for Engaging Sales Collateral to Bring New Hope and Treatment for Patients With Diabetic Gastroparesis.
Since 2009, the PM360 Trailblazer Awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. Initiatives are selected in 19 distinct categories. Both Silver and Gold winners were selected in each category for their ability to stand out in the complex, ever-changing healthcare environment, and were judged on content, format, success in reaching the targeted audience, and overall quality.
“Communication, connection, and engagement all took on new meanings these past 18 months as we were forced to isolate due to the pandemic,” says Anna Stashower, CEO and Publisher of PM360. “But marketers rose to the occasion exploring new technology, tactics, and strategies to help life sciences companies get their message out to customers with the information they needed. Our Initiative Award winners are a representation of that achievement and more, as several of these campaigns displayed deep empathy and understanding as well as a desire to reach a more diverse set of patients than ever before.”
EVERSANA earned GOLD in the Data/Analytics Category for ACTICS by EVERSANA and the company’s broader efforts to harness the power of data, analytics, and machine learning capabilities to improve the rare disease patient’s experience. Additionally the company earned SILVER winner in the Sales Aid Category, related to the “Spray Away” campaign, EVERSANA ENGAGE’s efforts to demonstrate the clear benefits of Gimoti, a novel nasal spray treatment for diabetic gastroparesis.
“Making an impact on patient lives is the number one goal of all campaigns and initiatives at EVERSANA,” said Jim Lang, CEO. “We are honored to be recognized by PM360 for our efforts in evolving the life sciences industry into the next phase of meeting and exceeding patient, provider and stakeholder needs.”
In total, 67 winners were honored across all categories during a virtual awards ceremony on September 23, 2021. The winners will be featured in the October issue of PM360 and on www.pm360online.com.
# # #
About PM360
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.
By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.